NCT03212404 Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03207347 A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001) Status COMPLETED Phase PHASE2
NCT03200587 Cabometyx and Avelumab in Patients With Metastatic Renal Cell Carcinoma (mRCC) Status COMPLETED Phase PHASE1
NCT03190174 Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers Status COMPLETED Phase PHASE1/PHASE2
NCT03189186 Phase-I Trial of Pembrolizumab and Percutaneous Cryoablation Combination Followed by Nephron-Sparing Surgery or Cytoreductive Nephrectomy in Locally Advanced and Metastatic Renal Cell Carcinomas Status WITHDRAWN Phase PHASE1
NCT03177239 Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602) Status UNKNOWN Phase PHASE2
NCT03176485 Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors Status COMPLETED Phase NA
NCT03173560 Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma Status COMPLETED Phase PHASE2
NCT03172754 Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03170960 Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03161145 A Study to Observe the Treatment Patterns and Outcomes of Patients in Japan With Kidney Cancer That is Unable to be Removed by Surgery or That Has Spread Status COMPLETED Phase N/A
NCT03142334 Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564) Status COMPLETED Phase PHASE3
NCT03141177 A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma Status COMPLETED Phase PHASE3
NCT03097328 Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma Status COMPLETED Phase PHASE2
NCT03094949 Comparison Between Partial Nephrectomy and Ablation for Renal Tumor Status UNKNOWN Phase NA
NCT03093688 Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor Status RECRUITING Phase PHASE1/PHASE2
NCT03063762 Study to Evaluate Safety, Pharmacokinetics and Therapeutic Activity of RO6874281 as a Combination Therapy in Participants With Unresectable Advanced and/or Metastatic Renal Cell Carcinoma (RCC) Status COMPLETED Phase PHASE1
NCT03052504 Prospective Versus Retrospective Complications in Radical Cystectomy and Nephrectomy Status COMPLETED Phase N/A